Morepen Laboratories Limited — Others, 13-05-2025: Copy of Newspaper Publication

Morepen Laboratories has announced a board meeting to approve the financial results for the quarter and half-year. For the quarter, consolidated total income was ₹465.85 Cr, with net profit at ₹20.31 Cr, down from ₹28.74 Cr a year ago. Full-year consolidated revenue rose to ₹1811.58 Cr, while net profit increased to ₹118.02 Cr from ₹96.62 Cr previously. Earnings per share improved to ₹2.20 from ₹1.88, signaling steady annual profit growth despite a quarterly dip.